You just read:

ESC Congress 2016 Late Breaking Science Registry: Latest Data on Pradaxa® (dabigatran etexilate mesylate) Safety and Effectiveness Profile Show Low Rates of Bleeding and Stroke in NVAF Patients in Routine Clinical Care

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

29 Aug, 2016, 12:45 ET